135 related articles for article (PubMed ID: 17478078)
1. Proinvasive activity of BMP-7 through SMAD4/src-independent and ERK/Rac/JNK-dependent signaling pathways in colon cancer cells.
Grijelmo C; Rodrigue C; Svrcek M; Bruyneel E; Hendrix A; de Wever O; Gespach C
Cell Signal; 2007 Aug; 19(8):1722-32. PubMed ID: 17478078
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells.
Deng H; Makizumi R; Ravikumar TS; Dong H; Yang W; Yang WL
Exp Cell Res; 2007 Mar; 313(5):1033-44. PubMed ID: 17275810
[TBL] [Abstract][Full Text] [Related]
3. The extracellular calcium-sensing receptor reciprocally regulates the secretion of BMP-2 and the BMP antagonist Noggin in colonic myofibroblasts.
Peiris D; Pacheco I; Spencer C; MacLeod RJ
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G753-66. PubMed ID: 17138967
[TBL] [Abstract][Full Text] [Related]
4. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
5. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.
Lai TH; Fong YC; Fu WM; Yang RS; Tang CH
Prostate; 2008 Sep; 68(12):1341-53. PubMed ID: 18512729
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats.
Maric I; Poljak L; Zoricic S; Bobinac D; Bosukonda D; Sampath KT; Vukicevic S
J Cell Physiol; 2003 Aug; 196(2):258-64. PubMed ID: 12811818
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
8. The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer.
Kodach LL; Bleuming SA; Musler AR; Peppelenbosch MP; Hommes DW; van den Brink GR; van Noesel CJ; Offerhaus GJ; Hardwick JC
Cancer; 2008 Jan; 112(2):300-6. PubMed ID: 18008360
[TBL] [Abstract][Full Text] [Related]
9. Smad4-independent TGF-beta signaling in tumor cell migration.
Giehl K; Imamichi Y; Menke A
Cells Tissues Organs; 2007; 185(1-3):123-30. PubMed ID: 17587818
[TBL] [Abstract][Full Text] [Related]
10. Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation.
Otani H; Otsuka F; Inagaki K; Takeda M; Miyoshi T; Suzuki J; Mukai T; Ogura T; Makino H
Am J Physiol Renal Physiol; 2007 May; 292(5):F1513-25. PubMed ID: 17244894
[TBL] [Abstract][Full Text] [Related]
11. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
13. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.
Kodach LL; Wiercinska E; de Miranda NF; Bleuming SA; Musler AR; Peppelenbosch MP; Dekker E; van den Brink GR; van Noesel CJ; Morreau H; Hommes DW; Ten Dijke P; Offerhaus GJ; Hardwick JC
Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510
[TBL] [Abstract][Full Text] [Related]
14. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac.
De Wever O; Nguyen QD; Van Hoorde L; Bracke M; Bruyneel E; Gespach C; Mareel M
FASEB J; 2004 Jun; 18(9):1016-8. PubMed ID: 15059978
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration.
Dise RS; Frey MR; Whitehead RH; Polk DB
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G276-85. PubMed ID: 17991704
[TBL] [Abstract][Full Text] [Related]
16. Functional role of bone morphogenetic protein-4 in isolated canine parietal cells.
Nitsche H; Ramamoorthy S; Sareban M; Pausawasdi N; Todisco A
Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G607-14. PubMed ID: 17600042
[TBL] [Abstract][Full Text] [Related]
17. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
Ye L; Lewis-Russell JM; Kynaston H; Jiang WG
J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein-4 inhibits heat-induced apoptosis by modulating MAPK pathways in human colon cancer HCT116 cells.
Deng H; Ravikumar TS; Yang WL
Cancer Lett; 2007 Oct; 256(2):207-17. PubMed ID: 17640799
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.
Ye L; Kynaston H; Jiang WG
Mol Cancer Res; 2008 Oct; 6(10):1594-606. PubMed ID: 18922975
[TBL] [Abstract][Full Text] [Related]
20. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells.
Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Simioni C; Leung E; Maclennan S; Baraldi PG; Borea PA
Mol Pharmacol; 2007 Aug; 72(2):395-406. PubMed ID: 17488804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]